ClinicalTrials.gov
ClinicalTrials.gov Menu

Rituximab Vasculitis Maintenance Study (RITAZAREM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01697267
Recruitment Status : Active, not recruiting
First Posted : October 2, 2012
Last Update Posted : July 23, 2018
Sponsor:
Collaborators:
Arthritis Research UK
Roche Pharma AG
Genentech, Inc.
University of Pennsylvania
Information provided by (Responsible Party):
David Jayne, Cambridge University Hospitals NHS Foundation Trust

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : December 2019
  Estimated Study Completion Date : December 2019
Publications:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):